Gene · 5887
Papers1,572
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,572
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of GTF2H1 and RAD54L2 polymorphisms on the risk of lung cancer in the Chinese Han population. | BMC Cancer | 2022 | 36384536 | PubTator, text mining | PubMed |
| Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation. | RNA Biol | 2022 | 36382943 | PubTator, text mining | PubMed |
| Iron: Not Just a Passive Bystander in AITD. | Nutrients | 2022 | 36364944 | PubTator, text mining | PubMed |
| Interplay between the DNA Damage Response and Immunotherapy Response in Cancer. | Int J Mol Sci | 2022 | 36362142 | PubTator, text mining | PubMed |
| The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer. | Cancers (Basel) | 2022 | 36358724 | PubTator, text mining | PubMed |
| Treatment of Human HeLa Cells with Black Raspberry Extracts Enhances the Removal of DNA Lesions by the Nucleotide Excision Repair Mechanism. | Antioxidants (Basel) | 2022 | 36358482 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer. | Front Immunol | 2022 | 36341328 | PubTator, text mining | PubMed |
| ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma. | Front Surg | 2022 | 36338658 | PubTator, text mining | PubMed |
| The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy. | Int J Mol Sci | 2022 | 36293356 | PubTator, text mining | PubMed |
| Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma. | Biomed Res Int | 2022 | 36281462 | PubTator, text mining | PubMed |
| Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells. | Front Genet | 2022 | 36276982 | PubTator, text mining | PubMed |
| Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches. | PLoS One | 2022 | 36264868 | PubTator, text mining | PubMed |
| Genetic susceptibility of bladder cancer in the Lebanese population. | BMC Med Genomics | 2022 | 36253817 | PubTator, text mining | PubMed |
| Metallo-Drugs in Cancer Therapy: Past, Present and Future. | Molecules | 2022 | 36235023 | PubTator, text mining | PubMed |
| Saccharomyces cerevisiae as a Model System for Eukaryotic Cell Biology, from Cell Cycle Control to DNA Damage Response. | Int J Mol Sci | 2022 | 36232965 | PubTator, text mining | PubMed |
| PFOA-Induced Ovotoxicity Differs Between Lean and Obese Mice With Impacts on Ovarian Reproductive and DNA Damage Sensing and Repair Proteins. | Toxicol Sci | 2022 | 36214631 | PubTator, text mining | PubMed |
| Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation. | Front Mol Biosci | 2022 | 36200070 | PubTator, text mining | PubMed |
| A protein with broad functions: damage-specific DNA-binding protein 2. | Mol Biol Rep | 2022 | 36190612 | PubTator, text mining | PubMed |
| Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. | Front Endocrinol (Lausanne) | 2022 | 36187110 | PubTator, text mining | PubMed |
| The Mechano-Ubiquitinome of Articular Cartilage: Differential Ubiquitination and Activation of a Group of ER-Associated DUBs and ER Stress Regulators. | Mol Cell Proteomics | 2022 | 36182100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5887/papers?page=9